NYSE:BIO

Bio-Rad Laboratories Earnings Date, Estimates, & History

$721.48

+1.37 (+0.19 %)

(As of 10/15/2021 12:00 AM ET)

Add

Compare

Today's Range

$713.22

▼

$725.47

50-Day Range

$708.84

▼

$825.77

52-Week Range

$507.22

▼

$832.70

Volume100,900 shs

Average Volume156,088 shs

Market Capitalization$21.48 billion

P/E Ratio5.38

Dividend YieldN/A

Beta0.85

Upcoming
Earnings Date
Oct. 28
Confirmed

Actual EPS
(Jul. 28)
$3.54
Beat By $0.88

Consensus EPS
(Jul. 28)
$2.66

Last Year's Q3 EPS
(7/30/2020)
$1.61

Read Call Transcript

Listen to Call

Earnings Per Share Revenue

Bio-Rad Laboratories Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Bio-Rad Laboratories Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Bio-Rad Laboratories (NYSE:BIO) Earnings Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2021	1	$2.50	$2.50	$2.50
Q2 2021	1	$2.56	$2.56	$2.56
Q3 2021	1	$2.18	$2.18	$2.18
Q4 2021	1	$2.51	$2.51	$2.51
FY 2021	4	$9.75	$9.75	$9.75
Q1 2022	1	$2.85	$2.85	$2.85
Q2 2022	1	$3.05	$3.05	$3.05
Q3 2022	1	$2.94	$2.94	$2.94
Q4 2022	1	$3.16	$3.16	$3.16
FY 2022	4	$12.00	$12.00		$12.00

BIO Earnings Information

Bio-Rad Laboratories last announced its quarterly earnings data on July 28th, 2021. The medical research company reported $3.54 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.66 by $0.88. The company earned $715.93 million during the quarter, compared to analyst estimates of $610.40 million. Bio-Rad Laboratories has generated $10.52 earnings per share over the last year ($134.15 diluted earnings per share) and currently has a price-to-earnings ratio of 5.4. Earnings for Bio-Rad Laboratories are expected to decrease by -13.03% in the coming year, from $14.20 to $12.35 per share. Bio-Rad Laboratories has confirmed that its next quarterly earnings report will be published on Thursday, October 28th, 2021.

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
10/28/2021 (Confirmed)		$2.30
7/28/2021	6/30/2021	$2.66	$3.54	+$0.88	($23.24)	$610.40 million	$715.93 million
4/29/2021	3/31/2021	$2.50	$5.21	+$2.71	($21.96)	$661.00 million	$726.80 million
2/10/2021	12/31/2020	$3.30	$4.01	+$0.71	($19.79)	$681.80 million	$789.84 million
10/29/2020	9/30/2020	$1.85	$3.00	+$1.15	($37.64)	$567.35 million	$647.26 million
7/30/2020	Q2 2020	$1.22	$1.61	+$0.39	($28.93)	$526.80 million	$536.88 million
5/6/2020	3/31/2020	$1.57	$1.91	+$0.34	($18.90)	$545.70 million	$571.60 million
2/13/2020	Q4 2019	$2.44	$2.32	($0.12)	($13.67)	$636.50 million	$624.43 million
10/31/2019	Q3	$1.36	$1.61	+$0.25	$11.90	$561.40 million	$560.60 million
8/1/2019	Q2 2019	$1.39	$1.57	+$0.18	($16.72)	$564.88 million	$572.60 million
5/8/2019	3/31/2019	$1.12	$1.65	+$0.53	($25.44)	$548.82 million	$553.98 million

2/28/2019	Q4 2018	$1.61	$2.13	+$0.52	$32.14	$610.65 million	$617.54 million
11/1/2018	9/30/2018	$1.16	$0.91	($0.25)	($7.07)	$541.23 million	$545.10 million
8/7/2018	Q2 2018	$1.27	$1.64	+$0.37	($5.59)	$551.05 million	$575.91 million
5/8/2018	Q1 2018	$1.07	$1.17	+$0.10	($19.43)	$527.20 million	$551.52 million
2/27/2018	Q4 2017	$1.28	$1.50	+$0.22	$0.68	$618.89 million	$620.43 million
11/2/2017	Q3 2017	$0.54	$0.91	+$0.37	$0.91	$507.99 million	$535.00 million
8/3/2017	Q2 2017	$0.63	$0.58	($0.05)	$0.99	$515.04 million	$504.67 million
5/4/2017	Q1 2017	$0.27	$0.41	+$0.14	$0.41	$477.76 million	$500.05 million
2/23/2017	Q416	$1.03	($0.70)	($1.73)	$3.20	$574.40 million	$571.45 million
11/1/2016	Q316	$0.51	$0.62	+$0.11	$0.62	$480.60 million	$508.75 million
8/3/2016	Q2	$1.13	$0.61	($0.52)	$0.61	$497.80 million	$516.80 million
5/5/2016	Q1	$0.60	$0.42	($0.18)	$0.42	$463.90 million	$471.20 million
2/25/2016	Q415	$1.27	$1.68	+$0.41	$1.68	$570.80 million	$570.56 million
11/3/2015	Q315	$0.54	$0.59	+$0.05	$0.59	$495.55 million	$469.96 million
8/6/2015	Q215	$0.78	$0.97	+$0.19	$0.97	$494.85 million	$506.10 million
5/5/2015	Q115	$0.33	$0.61	+$0.28	$0.61	$474.60 million	$472.80 million
2/26/2015	Q414	$1.18	$1.34	+$0.16	$1.34	$593.41 million	$598.20 million
11/4/2014	Q314	$0.86	$0.39	($0.47)	$0.39	$525.40 million	$530.64 million
8/5/2014	Q214	$0.95	$1.09	+$0.14	$1.09	$537.58 million	$536.80 million
5/6/2014	Q114	$0.80	$0.23	($0.57)	$0.23	$515.00 million	$509.30 million
2/27/2014	Q413	$1.42	$1.04	($0.38)		$586.67 million	$602.60 million
11/8/2013	Q3 2013	$0.66	$0.56	($0.10)	$1.37	$529.02 million	$505.10 million
8/6/2013	Q2 2013	$1.12	$1.20	+$0.08	$1.20	$532.60 million	$525.30 million
5/7/2013	Q1 2013	$1.10	$0.68	($0.42)	$0.68	$506.34 million	$499.70 million
2/26/2013	Q4 2012	$1.33	$1.65	+$0.32		$558.68 million	$573.80 million
11/6/2012	Q312	$1.14	$1.48	+$0.34		$507.79 million	$498.70 million
8/7/2012		$1.19	$1.69	+$0.50
5/1/2012		$1.02	$1.09	+$0.07
2/23/2012		$1.67	$2.08	+$0.41
11/1/2011		$1.53	$1.61	+$0.08
8/2/2011		$1.47	$1.41	($0.06)
5/3/2011		$1.32	$1.16	($0.16)
2/24/2011		$1.35	$2.41	+$1.06
11/2/2010	Q3 2010	$1.17	$1.59	+$0.42	$1.59
8/3/2010	Q2 2010	$1.27	$1.35	+$0.08	$1.35
5/4/2010	Q1 2010	$1.17	$1.24	+$0.07	$1.24
2/24/2010	Q4 2009	$1.08	$1.49	+$0.41	$1.63
11/3/2009	Q3 2009	$1.00	$1.38	+$0.38	$1.38
8/4/2009	Q2 2009	$1.03	$1.37	+$0.34	$1.37
5/5/2009	Q1 2009	$0.98	$1.10	+$0.12	$1.10
2/26/2009	Q4 2008	$0.90	$1.18	+$0.28	$2.66
11/6/2008	Q3 2008	$1.06	$1.01	($0.05)	$1.01
8/5/2008	Q2 2008	$1.08	$1.58	+$0.50	$1.58
5/6/2008	Q1 2008	$0.99	$0.97	($0.02)	$0.97
2/28/2008	Q4 2007	$0.80	$0.92	+$0.12	$1.39

(Earnings results data provided by Zacks Investment Research)

Bio-Rad Laboratories (NYSE:BIO) Earnings Frequently Asked Questions

When is Bio-Rad Laboratories's earnings date?: Bio-Rad Laboratories has confirmed that its next quarterly earnings data will be published on Thursday, October 28th, 2021. Learn more on BIO's earnings history
Did Bio-Rad Laboratories beat their earnings estimates last quarter?: In the previous quarter, Bio-Rad Laboratories (NYSE:BIO) reported $3.54 earnings per share (EPS) to beat the analysts' consensus estimate of $2.66 by $0.88. Learn more on BIO's earnings details
How can I listen to Bio-Rad Laboratories's earnings conference call?: The conference call for Bio-Rad Laboratories's latest earnings report can be listened to online. Listen to Conference Call
How can I read Bio-Rad Laboratories's conference call transcript?: The conference call transcript for Bio-Rad Laboratories's latest earnings report can be read online. Read Transcript

How much revenue does Bio-Rad Laboratories generate each year?: Bio-Rad Laboratories (NYSE:BIO) has a recorded annual revenue of $2.55 billion.
How much profit does Bio-Rad Laboratories generate each year?: Bio-Rad Laboratories (NYSE:BIO) has a recorded net income of $3.81 billion. BIO has generated $10.52 earnings per share over the last four quarters.
What is Bio-Rad Laboratories's price-to-earnings ratio?: Bio-Rad Laboratories (NYSE:BIO) has a trailing price-to-earnings ratio of 5.38 and a forward price-to-earnings ratio of 50.81.
What is Bio-Rad Laboratories's EPS forecast for next year?: Bio-Rad Laboratories's earnings are expected to decrease from $14.20 per share to $12.35 per share in the next year, which is a -13.03% change.

This page was last updated on 10/16/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.